Who founded Holoclara?

Holoclara was founded by Andrea Choe, Paul W. Sternberg, Frank C. Schroeder.

Who are Holoclara's investors?

Holoclara's investors include Horizons Ventures, Bold Capital Partners, Endurance28, FREEFLOW, Kairos Venture Investments, Llc, SV Latam Capital.

How much funding has Holoclara raised?

Holoclara has disclosed $16M raised across 1 round.

Holoclara

7 employees on LinkedIn · 6 known investors

Find your way into Holoclara

Paths you didn't know you had: your email and LinkedIn already hold routes to the Holoclara team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging. The company aims to reintroduce beneficial worm-derived components without live worms.

Biotech Healthtech Longevity

Founders & leadership

Andrea ChoeCEO / Co-Founder

Paul W. Sternberg Co-FounderPaul W. Sternberg is a basic scientist and Chair of Caltech's Biology and Biological Engineering Division who has conducted research in genetics, molecular biology, genomics, and other techniques, with particular focus on C. elegans. He is co-founder of Holoclara, which develops therapeutics derived from symbiotic intestinal organisms to address chronic disease and immune-related conditions.

Frank C. SchroederCo-Founder

Investors · 6

Horizons Ventures✓ confirmed by HoloclaraHong Kong · $500K – $10M

How we know: the company's own site · funding news · Not right? Tell us

Bold Capital Partnerslisted by Bold Capital PartnersSanta Monica

How we know: Bold Capital Partners's portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Endurance28listed by Endurance28San Francisco

How we know: Endurance28's portfolio page · funding news · Not right? Tell us

FREEFLOWlisted by FREEFLOWBerkeley

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Kairos Venture Investments, Llclisted by Kairos Venture Investments, LlcBeverly Hills · $150K – $20M

How we know: Kairos Venture Investments, Llc's portfolio page · Not right? Tell us

SV Latam Capitallisted by SV Latam CapitalSan Francisco · $50K – $500K

How we know: SV Latam Capital's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

$16M disclosed across 1 round · 2024

$16MSeries AJun 2024 · 4 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Press - Holoclaraholoclara.com · Aug 2025

Holoclara | Holoclara’s Series A Financing featured in exclusive Fortune coverage.holoclara.com · Jun 2024

Frequently asked questions

What does Holoclara do?: Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging. The company aims to reintroduce beneficial worm-derived components without live worms.
Who founded Holoclara?: Holoclara was founded by Andrea Choe, Paul W. Sternberg, Frank C. Schroeder.
Who are Holoclara's investors?: Holoclara's investors include Horizons Ventures, Bold Capital Partners, Endurance28, FREEFLOW, Kairos Venture Investments, Llc, SV Latam Capital.
How much funding has Holoclara raised?: Holoclara has disclosed $16M raised across 1 round.